Congress examining drug price increases.
MS drug manufacturers in the sights of two members of Congress
The companies are Bayer, Biogen, EMD Serono, Novartis, Sanofi Genzyme, Teva, and Roche.
U.S. Reps. Elijah Cummings and Peter Welch, two Democrats who sit on the House Committee on Oversight and Government Reform, are concerned about what they’re calling dramatic price increases for some MS drugs produced by those companies. In a news release, the congressmen say the price hikes have come “without warning, cause, or justification.”
They’ve sent letters to the companies seeking information about their profits and expenses. The letters also ask for documents about pricing strategies, patient assistance programs, and drug distribution systems.
Read full article: MS Drug Price Increases Grab Congressmen’s Interest, but Why?
|Read Full Article: MS Drug Price Increases Grab Congressmen’s Interest, but Why?|